Chinese Academy of Sciences: My bio-pharmaceutical industry prospects in 5 fields

Xinhua Xinhua Kunming December 4 (Xinhua Wu Xiaoyang) Chinese Academy of Sciences, Nankai University President Rao and 3 said in a speech in Kunming, China bio-pharmaceutical industry is expected to be developed into 600 000 000 000 -8 000 billion of the pillar industries, the focus direction including the development of new vaccines and improve 

Xinhua 

Xinhua Kunming, December 4 (Xinhua Wu Xiaoyang) Chinese Academy of Sciences, Nankai University President Rao and 3, said in a speech in Kunming, China bio-pharmaceutical industry is expected to grow into a pillar 600 000 000 000 -8 000 billion industry, including key directions development of new vaccines and the transformation of traditional vaccines, protein drugs, antibody drugs and the industrialization of biotechnology drugs, disease diagnosis and detection of major research and product development, gene therapy and cell therapy and other biological treatment technology, regenerative medicine research and application technologies . 

Zihe Rao, China's biomedical industry prospects, but the foundation is currently facing a smaller hail, the lack of top talent and creativity weak challenge. Most of the biotechnology innovation and patents from the developed countries, for example, 59% of biotechnology patents from the United States, 19% from Europe, 17% from Japan. The focus of bio-pharmaceutical industry development includes the following five aspects: 

One is to develop new vaccines and the transformation of traditional vaccines. China is the world's largest countries using the vaccine, the number of hundreds of millions of copies each year. Promote the use of vaccines for the average life expectancy in China increased significantly to make a significant contribution, but is still widely used in China 50 years ago or even earlier research and development of vaccines. Development of new vaccines and the transformation of traditional vaccines is an inevitable trend, which helps to significantly improve the ability of major infectious diseases prevention and control, but also to cultivate 100 000 000 000 -1 500 billion size of the vaccine industry. 

Second, protein drugs, antibody drugs and the industrialization of biotechnology drugs. For cancer, cardiovascular and cerebrovascular diseases and neurodegenerative diseases and autoimmune diseases, diabetes and other serious diseases that endanger people's health, biotechnology, pharmaceutical drugs has become the world's fastest-growing drug. The current market size of biotech drugs about 400 billion yuan, is expected to grow into the future 300 000 000 000 -5 000 billion industry. 

Third, disease diagnosis and detection of major research and product development. SARS, avian flu, tuberculosis and AIDS, and diseases such as influenza A H1N1 influenza outbreak, diagnostic techniques and requirements of the development of related industries. 500 billion is expected to grow into the future about the diagnosis and detection of regular City 

Fourth, strengthening gene therapy, cell therapy and other biological treatment technology. Currently, there are six to carry out stem cell therapy products in various stages of clinical trials, nucleic acid drug development to keep pace with the world. Stem Cells 2015, the medical world about the potential market of 800 million U.S. dollars, nucleic acid drug market will reach 2,000 billion U.S. dollars. China's future size of 100 billion yuan is expected to foster personalized treatment system. 

Fifth, the regenerative medicine research and application technologies. Global demand for tissue engineering products giant, is expected to develop tissue engineering products can be 800 billion dollars by 2020, city often, 95% of the transplanted cells, tissues and organs generated by tissue engineering. China due to trauma, disease and heredity, aging caused by the absence of many organs, is expected to foster the regeneration of 500 billion size of regular treatment and rehabilitation of municipal